XML 49 R18.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Fair Value Measurement
6 Months Ended
Jun. 30, 2011
Fair Value Measurement  
Fair Value Measurement 13.       Fair Value Measurement 

 

Authoritative guidance establishes a valuation hierarchy for disclosure of the inputs to the valuation used to measure fair value.  This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on our own assumptions used to measure assets and liabilities at fair value.  

 

The following tables present information about our assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2011 and December 31, 2010, and indicate the fair value hierarchy of the valuation techniques we utilized to determine such fair value.

 

 

                     
        Fair Value Measurement at June 30, 2011
Balance Sheet Classification Type of Instrument Total Level 1 Level 2 Level 3
Cash equivalents Institutional money market funds  $    222,110 -  $    222,110 -
Marketable securities Commercial paper  $        4,998 -  $        4,998 -
Marketable securities U.S. Corporate bonds  $      15,143 -  $      15,143 -
Other current assets Foreign exchange forward contracts  $        2,338 -  $        2,338 -
Other assets Foreign exchange forward contracts  $           408 -  $           408 -
Other current liabilities Foreign exchange forward contracts  $      17,476 -  $      17,476 -
Other liabilities Foreign exchange forward contracts  $        3,766 -  $        3,766 -
Contingent consideration Acquisition-related contingent consideration  $      17,601 - -  $ 17,601

 

                     
        Fair Value Measurement at December 31, 2010
Balance Sheet Classification Type of Instrument Total Level 1 Level 2 Level 3
Cash equivalents Institutional money market funds  $    186,565 -  $    186,565 -
Marketable securities Commercial paper  $      65,261 -  $      65,261 -
Marketable securities U.S. Corporate bonds  $      19,184 -  $      19,184 -
Marketable securities Federal agency obligations  $      10,015 -  $      10,015 -
Other current assets Foreign exchange forward contracts  $        9,365 -  $        9,365 -
Other assets Foreign exchange forward contracts  $           590 -  $           590 -
Other current liabilities Foreign exchange forward contracts  $      11,848 -  $      11,848 -
Other liabilities Foreign exchange forward contracts  $        3,380 -  $        3,380 -

 

 

The following table represents a roll-forward of the fair value of Level 3 instruments, comprised solely of acquisition-related contingent consideration:

 

 

    June 30,
2011
Balance at beginning of period -
Amounts acquired or issued        (16,720)
Change in fair value             (881)
Balance at end of period  $    (17,601)
     

 

Valuation Techniques 

                Items classified as Level 2 within the valuation hierarchy, consisting of an institutional money market fund held at a multinational financial institution and corporate and federal agency bonds and commercial paper are valued based upon pricing of securities with similar investment characteristics and holdings.  Our derivative assets and liabilities include foreign exchange derivatives that are measured at fair value using observable market inputs such as forward rates, interest rates, our own credit risk and our counterparties' credit risks. Based on these inputs, the derivative assets and liabilities are classified within Level 2 of the valuation hierarchy.  Item classified as Level 3 within the valuation hierarchy, consisting of contingent consideration liabilities related to the Taligen and Orphatec acquisitions, were valued based on various estimates, including probability of success, discount rates and amount of time until the conditions of the milestone payments are met. 

 

As of June 30, 2011, there has not been any impact to the fair value of our derivative liabilities due to our own credit risk.  Similarly, there has not been any significant adverse impact to our derivative assets based on our evaluation of our counterparties' credit risks.